Corporate & Business Development

Reimagining medicine through partnerships

With global biomedical innovation moving at an unparalleled pace, partnering fuels scientific progress and patient care. At Progressive, we're collaborating with innovators to address some of society's most challenging healthcare issues.

30+

strategic deals over the last 2+ years

~120

countries where Progressive products are sold

10.0 bn

R&D spend in 2024 (USD)

Partnering focus areas

We are an innovative medicines focused company working on four therapeutic areas and five technology platforms.

Therapeutic areas

Cardiovascular, renal & metabolic

Immunology

Neuroscience

Oncology

Our efforts include use of early interventions and development of pioneering treatments, from prevention to management, as well as the creation of innovative access models. Our goal is to reduce and ultimately stop premature death and disability from cardiovascular disease.

Technology platforms

Chemistry

Biotherapeutics

xRNA

Radioligand therapy

Cell and gene therapy

We aim to discover and develop breakthrough molecules by boldly enabling unprecedented biological space with suitably crafted compounds across diverse chemical modalities.

Other areas of interest

In addition to our areas of focus, Progressive also looks to partner in other disease, research, and technology areas.

Partnering is at the core of our business

We collaborate to address some of society's most challenging healthcare issues and have a unified partnering strategy fueled by clarity, agility, accountability, and efficiency.

Where to meet us

See which events Progressive will be attending.

Discover more

Leadership team

Get to know the Corporate & Business Development team

Our approach

Discover how we collaborate to address some of society's most challenging healthcare issues